Market-Moving News for February 1st
Market-Moving News for February 1st
2月1日的市场动向新闻
NRBO: 103% | NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity
NRBO：103% | NeuroBo Pharmaceuticals 宣布 FDA 批准用于治疗肥胖的 DA-1726 的 1 期临床试验
AUVI: 28% | EXCLUSIVE: Applied UV Tells Benzinga 'We estimate that potential revenues from this project could total $250 Million to $300 Million over the next 3 to 6 years'
AUVI：28% | 独家：应用紫外线告诉本辛加：“我们估计，未来3到6年，该项目的潜在收入总额可能达到2.5亿至3亿美元
GOOS: 12% | Canada Goose Hldgs Q3 2024 Adj EPS C$1.37, Inline, Sales C$609.90M Miss C$620.05M Estimate
GOOS：12% | 加拿大鹅控股公司2024年第三季度调整后每股收益1.37加元，联机，销售额为6.099亿加元，低于6.205亿加元的预期